Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 2/20 | 1.00 |
| ▸ | GUSB | P08236 | 1/20 | 1.00 |
| ▸ | MAOB | P27338 | 4/20 | 0.75 |
| ▸ | CHRNA7 | P36544 | 4/20 | 0.73 |
| ▸ | AR | P10275 | 5/20 | 0.69 |
| ▸ | MAPT | P10636 | 2/20 | 0.68 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.68 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.66 |
| ▸ | JUN | P05412 | 1/20 | 0.66 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.66 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.64 |
| ▸ | TP53 | P04637 | 1/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.64 |
| ▸ | HPGD | P15428 | 1/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.64 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.64 |
| ▸ | MAOA | P21397 | 1/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL130475 | 1.00 | BCHE (1.00) | BCHEGUSBMAOBCHRNA7AR | |
| SCHEMBL30791478 | 0.90 | BCHE (0.81) | BCHEGUSBMAOBCHRNA7AR | |
| SCHEMBL11595805 | 0.87 | BCHE (0.77) | BCHEGUSBMAOBCHRNA7AR | |
| SCHEMBL1649380 | 0.87 | BCHE (0.77) | BCHEGUSBMAOBCHRNA7AR | |
| SCHEMBL471832 | 0.87 | BCHE (0.77) | BCHEGUSBMAOBCHRNA7AR | |
| SCHEMBL8106959 | 0.86 | BCHE (0.75) | BCHEGUSBMAOBCHRNA7AR | |
| SCHEMBL6699827 | 0.86 | BCHE (0.75) | BCHEGUSBMAOBCHRNA7AR | |
| SCHEMBL675698 | 0.86 | BCHE (0.75) | BCHEGUSBMAOBCHRNA7AR | |
| SCHEMBL6699830 | 0.86 | BCHE (0.75) | BCHEGUSBMAOBCHRNA7AR | |
| SCHEMBL3611920 | 0.86 | BCHE (0.75) | BCHEGUSBMAOBCHRNA7AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 273 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260096569-A1 | EDIBLE COATING WITH ANTIMICROBIAL PROPERTIES | APEEL TECH INC (US) | 2026-04-09 | — | — | US | claimed |
| CN-116270771-B | Application of penthorum chinense pursh and extractive thereof | 浙江中医药大学 | 2025-04-18 | — | — | CN | claimed |
| EP-4496476-A1 | GAS PHASE TREATMENT OF PRODUCE | Apeel Technology, Inc. (US) | 2025-01-29 | — | — | EP | claimed |
| WO-2023183341-A1 | GAS PHASE TREATMENT OF PRODUCE | APEEL TECHNOLOGY, INC. (US) | 2023-09-28 | — | — | WO | claimed |
| CN-111556807-B | Laser releasable bonding material for 3D IC applications | 布鲁尔科技公司 | 2023-09-08 | — | — | CN | claimed |
| CN-116270771-A | Application of penthorum chinense pursh and extractive thereof | 浙江中医药大学 | 2023-06-23 | — | — | CN | claimed |
| CN-115927240-A | Flavone glycosyltransferase and coding gene and application thereof | 中国科学院大连化学物理研究所 | 2023-04-07 | — | — | CN | claimed |
| EP-4090167-A1 | EDIBLE COATING WITH ANTIMICROBIAL PROPERTIES | Apeel Technology, Inc. (US) | 2022-11-23 | — | — | EP | claimed |
| US-20220330565-A1 | EDIBLE COATING WITH ANTIMICROBIAL PROPERTIES | APEEL TECHNOLOGY, INC. | 2022-10-20 | — | — | US | claimed |
| WO-2022217089-A1 | EDIBLE COATING WITH ANTIMICROBIAL PROPERTIES | APEEL TECHNOLOGY, INC. (US) | 2022-10-13 | — | — | WO | claimed |
| WO-2003035900-A1 | ENZYME ACTIVITY INDICATORS | BURTON MICHAEL (GB) | 2003-05-01 | — | — | WO | claimed |
| US-20020164397-A1 | N-[N-(3, 3-DIMETHYLBUTYL)-L-ALPHA-ASPARTYL]-L-PHENYLALANINE 1-METHYL ESTER AS A SWEETENER IN CHEWING GUM | NUTRASWEET PROPERTY HOLDINGS, INC. | 2002-11-07 | — | — | US | claimed |
| EP-1139776-A1 | N-[N-(3,3-DIMETHYLBUTYL)-L-ALPHA-ASPARTYL]-L-PHENYLALANINE 1- METHYL ESTER AS A SWEETENER IN CHEWING GUM | The NutraSweet Company (US) | 2001-10-10 | — | — | EP | claimed |
| WO-2001028503-A1 | PERSONAL CARE PRODUCTS USING N-[N-(3,3-DIMETHYLBUTYL)-1-α-ASPARTYL]-L-PHENYLALANINE METHYL ESTER | THE NUTRASWEET COMPANY (US) | 2001-04-26 | — | — | WO | claimed |
| WO-2001028590-A2 | PHARMACEUTICAL COMPOSITIONS CONTAINING N-[N-(3,3-DIMETHYLBUTYL)-1-α-ASPARTYL]-L-PHENYLALANINE METHYL ESTER | THE NUTRASWEET COMPANY (US) | 2001-04-26 | — | — | WO | claimed |
| WO-2001010236-A1 | CONFECTIONERY FOOD PRODUCTS SWEETENED WITH N-[N-(3,3-DIMETHYLBUTYL)-1-α-ASPARTYL]-L-PHENYLALANINE METHYL ESTER | THE NUTRASWEET COMPANY (US) | 2001-02-15 | — | — | WO | claimed |
| WO-2000036924-A1 | N-[N-(3,3-DIMETHYLBUTYL)-L-α-ASPARTYL]-L-PHENYLALANINE 1-METHYL ESTER AS A SWEETENER IN CHEWING GUM | THE NUTRASWEET COMPANY (US) | 2000-06-29 | — | — | WO | claimed |
| EP-0370461-B1 | Chalcone derivatives and process for producing the same | DAINIPPON INK & CHEMICALS (JP) | 1995-06-28 | — | — | EP | claimed |
| US-5342904-A | Polymer modified adducts of epoxy resins and active hydrogen containing compounds containing mesogenic moieties | THE DOW CHEMICAL COMPANY (US) | 1994-08-30 | — | — | US | claimed |
| EP-0173748-B1 | PROCESS FOR PRODUCING SUBSTITUTED UNSATURATED SIX-MEMBERED RING COMPOUNDS FROM PHENOL DERIVATIVES | HIRAI, Hidefumi (JP) | 1990-01-03 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260096569-A1 | EDIBLE COATING WITH ANTIMICROBIAL PROPERTIES | CYP51A1, ERG28, NISCH | BCHE 2458/4885GUSB 559/4885MAOB 1312/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.